Publication:
Non-encapsulated Trichinella spp., T. papuae, diminishes severity of DSS-induced colitis in mice

dc.contributor.authorPoom Adisakwattanaen_US
dc.contributor.authorSupaporn Nuamtanongen_US
dc.contributor.authorTeera Kusolsuken_US
dc.contributor.authorMontri Chairojen_US
dc.contributor.authorPa Thai Yenchitsomanasen_US
dc.contributor.authorUrai Chaisrien_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-10-19T05:02:00Z
dc.date.available2018-10-19T05:02:00Z
dc.date.issued2013-08-20en_US
dc.description.abstractBackground: Helminths use various mechanisms to avoid host immunity and protect themselves from being eliminated. Despite evading host immune responses, immunosuppression and regulation mechanisms elicit functions that diminish the adverse effects of unrelated inflammatory diseases. Objective: We investigated whether helminthic infections can ameliorate inflammatory diseases. Methods: Mice were infected with Trichinella papuae and then subjected to induced colitis through the oral administration of dextran sulfate sodium (DSS). Macroscopic and microscopic examinations measured weight loss, stool consistency, gross bleeding, colon length, and tissue inflammation. In addition, cytokine expression was observed in colon tissue by SYBR real-time RT-PCR to investigate the Th1, Th2, and regulatory cytokines. Result: The results showed that T. papuae infection decreased the severity of DSS-induced colitis, including weight loss, bloody diarrhea, shortening of colon, and colon tissue damage in mice (p <0.05). The expression level of IL-4 was high in the colons of DSS-treated mice without helminthic infection, while infected mice with DSS treatment had lower IL-4 levels (p <0.05). Uninfected DSS-treated mice failed to produce IL-10 mRNA in colon tissue, which may cause more severe colitis. In contrast, prior T. papuae infection DSS-treated mice had IL-10 levels in the colon significant lower than the normal and infected control groups. Conclusion: Our data provide the evidence that prior T. papuae infection can ameliorate DSSinduced colitis in mice and may be considered for a novel therapeutic strategy against immunological diseases in the future.en_US
dc.identifier.citationAsian Pacific Journal of Allergy and Immunology. Vol.31, No.2 (2013), 106-114en_US
dc.identifier.doi10.12932/AP0238.31.2.2013en_US
dc.identifier.issn22288694en_US
dc.identifier.issn0125877Xen_US
dc.identifier.other2-s2.0-84881536226en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/31882
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84881536226&origin=inwarden_US
dc.subjectImmunology and Microbiologyen_US
dc.subjectMedicineen_US
dc.titleNon-encapsulated Trichinella spp., T. papuae, diminishes severity of DSS-induced colitis in miceen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84881536226&origin=inward

Files

Collections